These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11294191)

  • 1. [New indications for beta blockers. Cave hypertension focus/heart failure].
    MMW Fortschr Med; 2000 Jan; 142(1-2):52-3. PubMed ID: 11294191
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.
    Willenheimer R; van Veldhuisen DJ; Ponikowski P; Lechat P;
    J Am Coll Cardiol; 2005 Jul; 46(1):182. PubMed ID: 15992659
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
    Galatius S; Gustafsson F; Atar D; Hildebrandt PR
    Cardiology; 2004; 102(3):160-5. PubMed ID: 15334027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
    vom Dahl J; Schotten U; Sasse A
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comprehensive anti-adrenergic therapy. It can save the weak heart].
    MMW Fortschr Med; 2001 Jan; 143(4):45. PubMed ID: 11219285
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A COMET lost.
    Goldstein S
    Ital Heart J; 2003 Oct; 4(10):653-4. PubMed ID: 14664277
    [No Abstract]   [Full Text] [Related]  

  • 9. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
    Aygul N; Ozdemir K; Duzenli MA; Aygul MU
    Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker dose.
    Magrì D; Palermo P; Cauti FM; Contini M; Farina S; Cattadori G; Apostolo A; Salvioni E; Magini A; Vignati C; Alimento M; Sciomer S; Bussotti M; Agostoni P
    Cardiovasc Ther; 2012 Apr; 30(2):100-8. PubMed ID: 20553283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function.
    Law Y
    J Am Coll Cardiol; 2005 Jul; 46(1):181-2; author reply 183. PubMed ID: 15992657
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure.
    Miró Ò; Müller C; Martín-Sánchez FJ; Bueno H; Mebazaa A; Herrero P; Jacob J; Gil V; Escoda R; Llorens P;
    Clin Res Cardiol; 2016 Dec; 105(12):1021-1029. PubMed ID: 27379611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
    Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
    Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of beta-blockers for clinical practice].
    Yoshikawa T
    Nihon Rinsho; 2007 May; 65 Suppl 5():98-101. PubMed ID: 17571372
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta blockers and ACE inhibitors In heart failure to be combined at the beginning!].
    MMW Fortschr Med; 2002 Nov; 144(45):58. PubMed ID: 12534067
    [No Abstract]   [Full Text] [Related]  

  • 17. [A fairer comparison between carvedilol and metoprolol is still to be done].
    Johnsson G; Aberg J
    Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
    [No Abstract]   [Full Text] [Related]  

  • 18. Acutely decompensated systolic heart failure: effects of frequent doses of furosemide vs a single dose plus carvedilol on clinical status, neurohormonal activation and ventricular arrhythmias.
    Lobo-Vielma L; Colmenarez-Mendoza H; Donis JH; Sanchez F; Perez A; Villarroel V; Dávila DF
    Int J Cardiol; 2010 Oct; 144(2):302-3. PubMed ID: 19329199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
    Albrecht M; Haustein KO
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertension.
    Bakris GL; Weber MA
    Rev Cardiovasc Med; 2008; 9(2):96-105. PubMed ID: 18660730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.